ARCHIVES

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

This article is from The Cancer Letter archive.

Vol. 34 No. 41 | November 7, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Deputy Barker Hits FDA, Calls for New Incentives for Pharmaceutical Industry; Barker Co-Founded Dietary Supplements Firm

May 30, 2003

Philadelphia Group Begins BMT Trial for Breast Cancer

April 5, 1991

Brown Needs Decision By March 31; Sander Decline HEW Offer

March 4, 1977

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

January 28, 2011

DCCP Board Okays Concepts For Severn Contract Recompetitions, Denies Two Other

June 19, 1981

FDA Can’t Prohibit Distribution of Articles, Books On Off-Label Drug Use, Judge Rules

August 13, 1999